Literature DB >> 34353582

Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn.

Yogen Singh1, Satyan Lakshminrusimha2.   

Abstract

Persistent pulmonary hypertension of the newborn (PPHN) is a disorder of circulatory transition resulting in high pulmonary vascular resistance with extrapulmonary right-to-left shunts causing hypoxemia. There has been substantial gain in understanding of pathophysiology of PPHN over the past 2 decades, and biochemical pathways responsible for abnormal vasoconstriction of pulmonary vasculature are now better understood. Easy availability of bedside echocardiography helps in establishing early definitive diagnosis, understanding the pathophysiology and hemodynamic abnormalities, monitoring the disease process, and response to therapeutic intervention. There also has been significant advancement in specific management of PPHN targeted at deranged biochemical pathways and hemodynamic instability.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Echocardiography; Inhaled nitric oxide; Oxygen; Persistent pulmonary hypertension of the newborn (PPHN); Term infant

Mesh:

Substances:

Year:  2021        PMID: 34353582      PMCID: PMC8351908          DOI: 10.1016/j.clp.2021.05.009

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   2.642


  71 in total

1.  Optimal Oxygen Targets in Term Lambs with Meconium Aspiration Syndrome and Pulmonary Hypertension.

Authors:  Munmun Rawat; Praveen Chandrasekharan; Sylvia F Gugino; Carmon Koenigsknecht; Lori Nielsen; Stephen Wedgwood; Bobby Mathew; Jayasree Nair; Robin Steinhorn; Satyan Lakshminrusimha
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

2.  Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension.

Authors:  E M Bifano; A Pfannenstiel
Journal:  Pediatrics       Date:  1988-05       Impact factor: 7.124

3.  Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.

Authors:  D L Pearson; S Dawling; W F Walsh; J L Haines; B W Christman; A Bazyk; N Scott; M L Summar
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

4.  Persistent Pulmonary Hypertension of the Newborn.

Authors:  Satyan Lakshminrusimha; Martin Keszler
Journal:  Neoreviews       Date:  2015-12

Review 5.  Models of persistent pulmonary hypertension of the newborn (PPHN) and the role of cyclic guanosine monophosphate (GMP) in pulmonary vasorelaxation.

Authors:  R H Steinhorn; F C Morin; J R Fineman
Journal:  Semin Perinatol       Date:  1997-10       Impact factor: 3.300

6.  Nitric oxide activity through guanylate cyclase and phosphodiesterase modulation is impaired in fetal lambs with congenital diaphragmatic hernia.

Authors:  Anthony de Buys Roessingh; Virginie Fouquet; Yves Aigrain; Jean-Christophe Mercier; Pascal de Lagausie; Anh Tuan Dinh-Xuan
Journal:  J Pediatr Surg       Date:  2011-08       Impact factor: 2.545

7.  Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn.

Authors:  Kathryn N Farrow; Stephen Wedgwood; Keng Jin Lee; Lyubov Czech; Sylvia F Gugino; Satyan Lakshminrusimha; Paul T Schumacker; Robin H Steinhorn
Journal:  Respir Physiol Neurobiol       Date:  2010-09-06       Impact factor: 1.931

8.  Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.

Authors:  D D Ivy; J P Kinsella; S H Abman
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension.

Authors:  Satyan Lakshminrusimha; Daniel D Swartz; Sylvia F Gugino; Chang-Xing Ma; Karen A Wynn; Rita M Ryan; James A Russell; Robin H Steinhorn
Journal:  Pediatr Res       Date:  2009-11       Impact factor: 3.756

10.  Early use of combined exogenous surfactant and inhaled nitric oxide reduces treatment failure in persistent pulmonary hypertension of the newborn: a randomized controlled trial.

Authors:  Alvaro González; Aldo Bancalari; Waldo Osorio; Matías Luco; Agustina González; Héctor Pérez; Javier Kattan
Journal:  J Perinatol       Date:  2020-08-13       Impact factor: 2.521

View more
  1 in total

1.  Association of asymmetric dimethylarginine with the pathological process of persistent pulmonary hypertension of the newborn.

Authors:  Wen-Ting Zhang; Qin Lu; Jie-Jun Ding; Meng Gu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-01-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.